DK3110425T3 - Ikke-flygtig ophthalmisk sammensætning, især til behandling af tør-øje-syndrom - Google Patents

Ikke-flygtig ophthalmisk sammensætning, især til behandling af tør-øje-syndrom Download PDF

Info

Publication number
DK3110425T3
DK3110425T3 DK15713215T DK15713215T DK3110425T3 DK 3110425 T3 DK3110425 T3 DK 3110425T3 DK 15713215 T DK15713215 T DK 15713215T DK 15713215 T DK15713215 T DK 15713215T DK 3110425 T3 DK3110425 T3 DK 3110425T3
Authority
DK
Denmark
Prior art keywords
volatile
treatment
dry eye
ophthalmic composition
eye syndrome
Prior art date
Application number
DK15713215T
Other languages
English (en)
Inventor
Fabrice Mercier
Léopold Schmetterer
Original Assignee
Thea Lab
Medical Univ Of Vienna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thea Lab, Medical Univ Of Vienna filed Critical Thea Lab
Application granted granted Critical
Publication of DK3110425T3 publication Critical patent/DK3110425T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK15713215T 2014-02-28 2015-03-02 Ikke-flygtig ophthalmisk sammensætning, især til behandling af tør-øje-syndrom DK3110425T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1451662A FR3018045B1 (fr) 2014-02-28 2014-02-28 Composition ophtalmique remanente, notamment pour le traitement de la secheresse oculaire
PCT/FR2015/050499 WO2015136186A1 (fr) 2014-02-28 2015-03-02 Composition ophtalmique rémanente, notamment pour le traitement de la sécheresse oculaire

Publications (1)

Publication Number Publication Date
DK3110425T3 true DK3110425T3 (da) 2019-12-09

Family

ID=50624806

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15713215T DK3110425T3 (da) 2014-02-28 2015-03-02 Ikke-flygtig ophthalmisk sammensætning, især til behandling af tør-øje-syndrom

Country Status (13)

Country Link
EP (1) EP3110425B1 (da)
CY (1) CY1122457T1 (da)
DK (1) DK3110425T3 (da)
ES (1) ES2760523T3 (da)
FR (1) FR3018045B1 (da)
HR (1) HRP20192142T1 (da)
HU (1) HUE047396T2 (da)
LT (1) LT3110425T (da)
PL (1) PL3110425T3 (da)
PT (1) PT3110425T (da)
RS (1) RS59721B1 (da)
SI (1) SI3110425T1 (da)
WO (1) WO2015136186A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000008299A1 (it) * 2020-04-17 2021-10-17 Glycores 2000 Srl Composizione liquida oftalmica comprendente acido ialuronico lineare a basso peso molecolare
EP4039248A1 (en) * 2021-02-04 2022-08-10 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic composition
EP4218717A1 (en) 2022-02-01 2023-08-02 Laboratoires THEA Ophthalmic composition comprising resveratrol for treating dry eye syndrome

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004262777A (ja) * 2003-02-27 2004-09-24 Shiseido Co Ltd アセチル化ヒアルロン酸含有眼用医薬組成物
CN1302812C (zh) * 2004-11-30 2007-03-07 中国海洋大学 含海藻糖和玻璃酸的眼部用药传递系统及其制备方法
TWI393567B (zh) * 2005-03-31 2013-04-21 Bausch & Lomb 治療乾眼之組合物及相關之製造方法及使用方法
US20080095754A1 (en) * 2006-10-18 2008-04-24 Burke Susan E Ophthalmic compositions comprising diglycine
KR101433152B1 (ko) * 2006-12-22 2014-08-22 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. 안과용 약물의 전달에 유용한 젤
CN101691478A (zh) * 2009-09-25 2010-04-07 海昌隐形眼镜有限公司 含海藻糖的角膜接触镜护理组合物及其制备方法
CN101691479B (zh) * 2009-09-25 2013-01-16 海昌隐形眼镜有限公司 一种角膜接触镜保存液组合物及其制备方法
US20110319502A1 (en) * 2010-06-25 2011-12-29 Coffey Martin J Compositions and Methods for Enhancing Reduction of Spore-Forming Microorganisms
GB201017048D0 (en) * 2010-10-08 2010-11-24 Ucl Business Plc Composition

Also Published As

Publication number Publication date
PL3110425T3 (pl) 2020-03-31
FR3018045B1 (fr) 2017-06-16
CY1122457T1 (el) 2021-01-27
RS59721B1 (sr) 2020-01-31
FR3018045A1 (fr) 2015-09-04
ES2760523T3 (es) 2020-05-14
SI3110425T1 (sl) 2020-01-31
WO2015136186A1 (fr) 2015-09-17
PT3110425T (pt) 2019-12-11
EP3110425B1 (fr) 2019-11-13
LT3110425T (lt) 2019-12-10
HRP20192142T1 (hr) 2020-02-21
HUE047396T2 (hu) 2020-04-28
EP3110425A1 (fr) 2017-01-04

Similar Documents

Publication Publication Date Title
BR112016030368A2 (pt) composição oftálmica
DK3399962T3 (da) Oftalmisk sammensætning til behandling af tør øjensygdom
DK3492632T3 (da) Metoder til behandling af lithiumholdige materialer
DK3192902T3 (da) Fremgangsmåde til fremstilling af graphenholdige viscosefibre
DK3204417T3 (da) Cd73-blokering
DK3119397T3 (da) Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser
DK3722274T3 (da) 2-perfluorbutylpentan til oftalmisk indgivelse
DK3096741T3 (da) Fremgangsmåde til fremstillingen af hybridosomer
DK3556775T3 (da) Anti-lag-3 antistoffer til behandling af hæmatologiske maligniteter
DK3174858T3 (da) Fremgangsmåde til fremstilling af pyrazoler
DK3139903T3 (da) Vandig oftalmisk opløsning og fremgangsmåde til behandling af tørre øjne-syndrom
DK3040326T3 (da) Haloolefin-baseret sammensætning
DK3362066T3 (da) Kombinationsterapi til behandling af maligniteter
DK3240612T3 (da) Fremgangsmåder til behandling af nethindesygdomme
FR3024363B1 (fr) Composition thermogelifiable
DK3122349T3 (da) Sammensætninger til behandling af autodigestion
DK3210973T3 (da) Heteroarylforbindelser til behandling af oftalmiske sygdomme
CL2017000639A1 (es) Composición
DK3302573T3 (da) Sammensætning til behandlingen af hjernelæsioner
DK3216451T3 (da) Oftalmisk vandig sammensætning
DK3209295T3 (da) Fremgangsmåder til behandling af øjenlidelser
DK3164123T3 (da) Hidtil ukendte anvendelser af benzylidenguanidinderivater til behandling af proteopatier
DK3096775T3 (da) SOCS-mimetika til behandling af sygdomme
DK3452093T3 (da) Ophthalmiske sammensætninger
DK3110425T3 (da) Ikke-flygtig ophthalmisk sammensætning, især til behandling af tør-øje-syndrom